bioAffinity Technologies Files S-1/A Amendment
Ticker: BIAFW · Form: S-1/A · Filed: May 5, 2025 · CIK: 1712762
Sentiment: neutral
Topics: sec-filing, s-1/a, amendment, financials
TL;DR
bioAffinity Tech updated its S-1/A filing on 5/5/25. Check financials for 2022-2023.
AI Summary
bioAffinity Technologies, Inc. filed an S-1/A amendment on May 5, 2025, related to its 1933 Act registration. The company, based in San Antonio, TX, is involved in commercial physical and biological research. Financial details for the fiscal years ending December 31, 2022, and 2023, including common stock, preferred stock, additional paid-in capital, and retained earnings, are provided.
Why It Matters
This filing provides updated information for investors regarding bioAffinity Technologies' securities, crucial for understanding the company's financial standing and potential investment opportunities.
Risk Assessment
Risk Level: medium — S-1/A filings often indicate a company is preparing to raise capital or has undergone significant changes, which inherently carries investment risk.
Key Numbers
- 2022-12-31 — Fiscal Year End (Financial reporting period)
- 2023-12-31 — Fiscal Year End (Financial reporting period)
Key Players & Entities
- bioAffinity Technologies, Inc. (company) — Filer of the S-1/A
- 0001641172-25-008629 (filing_id) — Accession number for the filing
- 20250505 (date) — Filing date
- San Antonio, TX (location) — Company headquarters
- 333-286921 (registration_number) — SEC file number
FAQ
What is the primary purpose of this S-1/A filing?
The S-1/A filing is an amendment to a registration statement, typically used by companies to update information before or during a public offering of securities.
When was this specific amendment filed?
This amendment was filed on May 5, 2025.
What industry does bioAffinity Technologies, Inc. operate in?
bioAffinity Technologies, Inc. operates in SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH, with SIC code 8731.
What financial periods are covered by the data in this filing?
The filing includes financial data for the fiscal years ending December 31, 2022, and December 31, 2023.
Where is bioAffinity Technologies, Inc. located?
The company's business and mailing address is 3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX 78217.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on May 5, 2025 regarding bioAffinity Technologies, Inc. (BIAFW).